The Crohn’s & Colitis Congress® is a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association benefiting the GI community across the world and across the entire spectrum of clinical care and science.
Take advantage of the on-demand recordings of the live course to gain a multidisciplinary perspective on treating inflammatory bowel disease (IBD), discover different perspectives, gain practical information you can immediately implement, and hear about potential treatments on the horizon.
Learning Objectives:
- Analyze and evaluate the latest evidence and best practices to identify the strengths and limitations of emerging and novel therapeutic options for IBD.
- Assess and apply current and emerging innovations in disease monitoring and management of IBD to enhance patient care.
- Explore and discuss technological advancements' impact on the clinical practice of IBD management.
- Determine the optimal surgical management approach for patients with complex terminal ileal disease to improve outcomes.
- Evaluate the role of nutrition and dietary interventions in the management of IBD and incorporate appropriate strategies into patient care plans.
- Assess the impact of behavioral and lifestyle therapies in IBD management and integrate these approaches into comprehensive treatment plans.
Crohn's & Colitis Congress Chairs:
Peter D. R. Higgins, MD, PhD, AGAF
Co-Chair, Organizing Committee
University of Michigan
Laura E. H. Raffals, MD, MS
Co-Chair, Organizing Committee
Mayo Clinic
Price:
$325Sponsoring Societies
Commercial Supporters:
The 2024 Crohn’s & Colitis Congress was supported by an educational grant from:
- AbbVie Inc.
- Salix Pharmaceuticals, a division of Bausch Health US, LLC
- Pfizer Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions, please contact technical@playbacknow.com.